Title:
抗ＣＤ２２免疫療法によってがんを処置するための組成物および方法
Document Type and Number:
Japanese Patent JP7275118
Kind Code:
B2
Abstract:
Chimeric antigen receptors (CARs) containing CD22 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARsare also disclosed. Methods of treating or preventing cancer in a subject, and methods of making CAR T cells are also disclosed.
Inventors:
Orentas, Limas Jay
Schneider, Dina
Doroprik, Boro
Dimitrov, Dimita S
Chu, Zhong Yui
Schneider, Dina
Doroprik, Boro
Dimitrov, Dimita S
Chu, Zhong Yui
Application Number:
JP2020521362A
Publication Date:
May 17, 2023
Filing Date:
October 16, 2018
Export Citation:
Assignee:
LENTIGEN TECHNOLOGY, INC.
International Classes:
A61K35/17; A61K39/395; A61K48/00; A61P35/00; A61P35/02; A61P37/04; C07K14/705; C07K16/28; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/12; C12N15/13; C12N15/62; C12N15/63
Domestic Patent References:
| JP2014534207A |
Foreign References:
| WO2016102965A1 |
Attorney, Agent or Firm:
Patent Attorney Fukami Patent Office
Previous Patent: Anti-IL-5Rα monoclonal antibody
Next Patent: Suction for grinding tools with radial brush plates
Next Patent: Suction for grinding tools with radial brush plates